open access
Evaluation of neuroendocrine tumors with 99mTc-EDDA/HYNIC TOC
open access
Abstract
BACKGROUND: This paper is the short review of our preliminary results obtained with 99mTc-EDDA/HYNIC-TOC.
MATERIAL AND METHODS: The total of 495 patients with different neuroendocrine tumors were investigated during last few years.
RESULTS: There have been 334 true positive (TP), 73 true negative (TN), 6 false positive (FP) and 82 false negative findings (FN). Diagnosis was made according to SPECT findings in 122 patients (25%). The mean T/NT ratio for TP cases was significantly higher (p < 0.01) on SPECT (3.12 ± 1.13) than on whole body scan (2.2 ± 0.75). According to our results, overall sensitivity of the method is 80%, specificity 92%, positive predictive value 98%, negative predictive value 47% and accuracy 82%. Fifteen TP patients underwent therapy with 90Y-DOTATATE.
CONCLUSION: Scintigraphy of neuroendocrine tumors with 99mTc-Tektrotyd is a useful method for diagnosis, staging and follow up of the patients suspected to have neuroendocrine tumors. SPECT had important role in diagnosis. It is also helpful in the appropriate choice of the therapy, including the peptide receptor radionuclide therapy. In the absence of 68Ga-labeled peptides and PET/CT, the special emphasize should be given to application of SPECT/CT as well as to the radioguided surgery.
Abstract
BACKGROUND: This paper is the short review of our preliminary results obtained with 99mTc-EDDA/HYNIC-TOC.
MATERIAL AND METHODS: The total of 495 patients with different neuroendocrine tumors were investigated during last few years.
RESULTS: There have been 334 true positive (TP), 73 true negative (TN), 6 false positive (FP) and 82 false negative findings (FN). Diagnosis was made according to SPECT findings in 122 patients (25%). The mean T/NT ratio for TP cases was significantly higher (p < 0.01) on SPECT (3.12 ± 1.13) than on whole body scan (2.2 ± 0.75). According to our results, overall sensitivity of the method is 80%, specificity 92%, positive predictive value 98%, negative predictive value 47% and accuracy 82%. Fifteen TP patients underwent therapy with 90Y-DOTATATE.
CONCLUSION: Scintigraphy of neuroendocrine tumors with 99mTc-Tektrotyd is a useful method for diagnosis, staging and follow up of the patients suspected to have neuroendocrine tumors. SPECT had important role in diagnosis. It is also helpful in the appropriate choice of the therapy, including the peptide receptor radionuclide therapy. In the absence of 68Ga-labeled peptides and PET/CT, the special emphasize should be given to application of SPECT/CT as well as to the radioguided surgery.
Keywords
scintigraphy, 99mTc-EDDA/HYNIC-TOC, NET, SPECT
Title
Evaluation of neuroendocrine tumors with 99mTc-EDDA/HYNIC TOC
Journal
Issue
Article type
Research paper
Pages
99-103
Published online
2016-07-29
Page views
2160
Article views/downloads
3920
DOI
Pubmed
Bibliographic record
Nucl. Med. Rev 2016;19(2):99-103.
Keywords
scintigraphy
99mTc-EDDA/HYNIC-TOC
NET
SPECT
Authors
Vera Artiko
Aida Afgan
Jelena Petrović
Branislava Radović
Nebojša Petrović
Marina Vlajković
Dragana Šobić-Šaranović
Vladimir Obradović